Home | Recruitment

Complete

Trials by recruitment status

Public Title Date of registration Sponsorsort icon
D-002 and glucosamine/chondroitin sulphate in osteoarthritis 27/06/2014 CPN
Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort. 27/10/2020 CPN
Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2 06/11/2020 CPN
Antioxidant efcts of Abexol in middle-aged and older subjects 20/03/2022 CPN
Perioperative administration of probiotics-colorectal cancer-operated by laparoscopy. 2011-05-19 CNCMA
Efficacy of laparoscopic Nissen -Rossetti fundoplication in the treatment of gastroesophageal reflux disease. 2011-05-06 CNCMA
Gallbladder retractor and Knot pusher with simultaneous coaxial traction : new laparoscopic instruments. 2008-07-29 CNCMA
Transthoracoscopic Sympathectomy T-3 and T-4 in moderate palmar Hyperhidrosis . 2013-05-24 CNCMA
Insufflation with CO2 versus room air in colonoscopy 09/10/2014 CNCMA
Effectiveness and Safety of Tenofovir + Lamivudine + Efavirenz Generic Scheme for the Treatment of HIV Infection / AIDS in Patients of the CLS,Colombia, 2012-2013. 2012-07-20 CLS
EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS 19/11/2015 CLS
ior EPOCIM ® in the management of anemia of the preterm infant.Phase IV. 2013-02-26 CIMAB
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). 2009-07-03 CIMAB
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. 2009-07-03 CIMAB
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. 2009-07-03 CIMAB
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. 2009-07-10 CIMAB
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. 2009-07-24 CIMAB
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. 2009-07-24 CIMAB
Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. 2009-08-20 CIMAB
Effectiveness and Safety of Nimotuzumab for the treatment of patients with glioma tumors 2009-09-18 CIMAB